Ticker Details
Kodiak Sciences Inc
IPO Date:	October 1, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.41B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.15 | 4.23%
Avg Daily Range (30 D):	$1.40 | 3.35%
Avg Daily Range (90 D):	$1.37 | 3.42%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.46M
Avg Daily Volume (90 D):	.55M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	51

Institutional Trades
Total Institutional Trades:	1,693
Avg Institutional Trade:	$2.34M
Avg Institutional Trade (30 D):	$2.62M
Avg Institutional Trade (90 D):	$2.81M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.96M
Avg Closing Trade (30 D):	$3.56M
Avg Closing Trade (90 D):	$4.25M
Avg Closing Volume:	73.73K

News

Jul 3, 2026 @ 1:59 PM Diabetic Retinopathy Pipeline Insight 2026: Compre... Source: Researchandmarkets.Com

Apr 17, 2026 @ 8:59 PM Russell 2000 Rips To Record High — Here Are... Source: Erica Kollmann

Sep 25, 2025 @ 2:34 PM Ameresco, Lithium Americas, Kodiak Sciences And Ot... Source: Avi Kapoor

Jan 10, 2025 @ 2:35 PM Diabetic Retinopathy Global Clinical Trials Review... Source: Researchandmarkets.Com

Jun 20, 2024 @ 12:23 PM Should You Hold Kodiak Sciences (KOD) Stock in You... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.19	$-1.05	$-.94
Diluted EPS	$-4.19	$-1.05	$-.94
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-241.99M	$-65.64M	$-58.16M
Operating Income / Loss	$-246.42M	$-66.84M	$-59.78M
Cost of Revenue
Net Cash Flow	$21.74M	$-43.63M	$-40.33M
PE Ratio